These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. WHO expert committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 2002; 902():i-vii, 1-208. PubMed ID: 12082969 [TBL] [Abstract][Full Text] [Related]
43. Gifts from industry: laundering money or supporting education? Waud DR JAMA; 1994 Feb; 271(7):505. PubMed ID: 8301763 [No Abstract] [Full Text] [Related]
48. [Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification?]. Schweim HG MMW Fortschr Med; 2005 Sep; 147(38):11. PubMed ID: 16218221 [No Abstract] [Full Text] [Related]
49. The use of essential drugs. WHO Expert Committee World Health Organ Tech Rep Ser; 2000; 895():1-61. PubMed ID: 11286007 [TBL] [Abstract][Full Text] [Related]
50. New Court guidance on repackaging of parallel traded products. Wright E; Clements SJ Drug Discov Today; 2007 Aug; 12(15-16):591-3. PubMed ID: 17706539 [No Abstract] [Full Text] [Related]
51. WHO views on responsibilities of research ethics boards and good clinical practice (GCP). Idänpään-Heikkilä J NCBHR Commun; 1993; 4(2):7-10. PubMed ID: 11652888 [No Abstract] [Full Text] [Related]
52. Rules aim to standardize recording of donations. Nemes J Mod Healthc; 1990 Aug; 20(33):76. PubMed ID: 10105816 [No Abstract] [Full Text] [Related]
53. Agencies fear global crises will lose out to tsunami donations. Butler D Nature; 2005 Jan; 433(7022):94. PubMed ID: 15650706 [No Abstract] [Full Text] [Related]
54. How to Engage Funders and Get Money: the 10 Rs You Need to Know. Hassmiller SB Am J Nurs; 2017 Apr; 117(4):63-65. PubMed ID: 28333747 [TBL] [Abstract][Full Text] [Related]
55. [Guidelines on drug donations are not sufficient for effective coordination: the case of Mostar in former Yugoslavia]. Quaglio G; Mezzelani P; Procacci P; Cuchillo C Epidemiol Prev; 2000; 24(3):120-2. PubMed ID: 10965607 [TBL] [Abstract][Full Text] [Related]
57. Counterfeit drugs: defining the problem and finding solutions. Wertheimer AI; Santella TM Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440 [TBL] [Abstract][Full Text] [Related]
58. FDA implementation of standards developed by the International Conference on Harmonisation. Booth PM Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561 [No Abstract] [Full Text] [Related]
59. The use of essential drugs. Report of a WHO expert committee. World Health Organ Tech Rep Ser; 1983; 685():1-46. PubMed ID: 6408810 [No Abstract] [Full Text] [Related]